ADCs
ADC Market Set to Boom: $47 Billion Jump Ahead, but Side Effects Still Pose Key Challenge
2024-11-19
JPM 2024: Biotech Companies Mapping Out Their Future, and a New Round of M&A Spree Begins
2024-01-09
Astellas, Seagen Cancer Drug Becomes First and Only Approved ADC For Advanced Urothelial Cancer in Japan
2021-09-28
LATEST
VintaBio Showcases High-Yield VintaProcess Platform for Gene Therapy Vector Production at ASGCT 2025
2025-05-15
Boehringer Ingelheim and Tempus AI Partner in Multi-Year Collaboration to Enhance Oncology Drug Development
2025-05-15
Study: Aligning U.S. Drug Prices with Europe Could Reduce American Life Expectancy by Six Months
2025-05-15